atorvastatin has been researched along with Kidney Tubular Necrosis, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Also, MA; Bastida, C; Letang, E; Miró, JM; Pericas, JM; Tuset, M | 1 |
| Cekmen, M; Ilbey, YO; Ozbek, E; Polat, EC; Simsek, A; Somay, A | 1 |
2 other study(ies) available for atorvastatin and Kidney Tubular Necrosis, Acute
| Article | Year |
|---|---|
[Rhabdomyolysis and severe hepatotoxicity due to a drug-drug interaction between ritonavir and simvastatin. Could we use the most cost-effective statin in all human immunodeficiency virus-infected patients?].
Topics: Antiretroviral Therapy, Highly Active; Atorvastatin; Chemical and Drug Induced Liver Injury; Comorbidity; Contraindications; Cost-Benefit Analysis; Cytochrome P-450 CYP3A Inhibitors; Drug Substitution; Drug Synergism; Dyslipidemias; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubular Necrosis, Acute; Middle Aged; Rhabdomyolysis; Ritonavir; Simvastatin | 2014 |
Atorvastatin prevents gentamicin-induced renal damage in rats through the inhibition of p38-MAPK and NF-kappaB pathways.
Topics: Analysis of Variance; Animals; Atorvastatin; Chi-Square Distribution; Disease Models, Animal; Free Radical Scavengers; Gentamicins; Heptanoic Acids; Immunohistochemistry; Kidney Function Tests; Kidney Tubular Necrosis, Acute; Male; MAP Kinase Signaling System; NF-kappa B; Nitric Oxide; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Probability; Pyrroles; Random Allocation; Rats; Rats, Wistar | 2009 |